Frequently Asked Questions
The market is segmented based on , By Product Type (Microfluidic-Based Devices and Microfluidic Components), Material (Polymer, Glass, Silicon, Metal, Ceramics, PDMS, Other), Technology (Medical/Healthcare, Non-medical), Application (In Vitro diagnostics, Point-of-Care Testing, Clinical Diagnostics, Pharmaceutical Research, Lab Analytics, Microdispensing, Microreaction, Drug Delivery, Laboratory Testing, Analytical Testing, High Throughput Screening), Sector (Industrial, Healthcare, In-vitro Diagnostics, Environmental Research, Clinical Diagnostics), End User (Hospitals and Diagnostic Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies) – Industry Trends and Forecast to 2031.
.
The Global Microfluidics Market size was valued at USD 26.65 USD Billion in 2023.
The Global Microfluidics Market is projected to grow at a CAGR of 15.01% during the forecast period of 2024 to 2031.
The major players operating in the market include Market players covered: Danaher, Thermo Fisher Scientific , PerkinElmer , Agilent Technologies , Bio-Rad Laboratories , BD, Illumina , F. Hoffmann-La Roche, Fluidigm Corporation, Dolomite Microfluidics, QIAGEN, Abbott, BIOMÉRIEUX, microfluidic ChipShop GmbH, Elveflow, Cellix Bio., Micronit B.V., PARKER HANNIFIN CORP, Fortive
-.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
